Co-administration of atazanavir with proton-pump inhibitors and H2 blockers.
Khanlou
Homayoun
H
Farthing
Charles
C
D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D000069446:Atazanavir Sulfate; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D006635:Histamine H2 Antagonists / Q000008:administration & dosage*; D006801:Humans; D009842:Oligopeptides / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D011725:Pyridines / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D012189:Retrospective Studies
D000897:Anti-Ulcer Agents; D017320:HIV Protease Inhibitors; D006635:Histamine H2 Antagonists; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate